奎奴普丁-达福普汀（Synercid）与利福平联合使用，在实验性金黄色葡萄球菌人工关节感染中具有高度协同作用。
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
作者信息
Saleh-Mghir Azzam, Ameur Nourdine, Muller-Serieys Claudette, Ismael Farid, Lemaitre Françoise, Massias Laurent, Feger Céline, Bléton Rémy, Crémieux Anne-Claude
机构信息
INSERM EMI-U 9933, Hôpital Bichat-Claude Bernard, Paris, France.
出版信息
Antimicrob Agents Chemother. 2002 Apr;46(4):1122-4. doi: 10.1128/AAC.46.4.1122-1124.2002.
Abstract
We compared the efficacies of quinupristin-dalfopristin (Q-D; 30 mg/kg of body weight every 8 h) and vancomycin (60 mg/kg twice daily), alone or in combination with rifampin (10 mg/kg twice daily), in a rabbit model of methicillin-resistant Staphylococcus aureus knee prosthesis infection. In contrast to vancomycin, Q-D significantly reduced the mean log(10) CFU per gram of bone versus that for the controls. The combination of rifampin with either Q-D or vancomycin was significantly more effective than monotherapy.
摘要
我们在耐甲氧西林金黄色葡萄球菌人工膝关节感染的兔模型中，比较了奎奴普丁-达福普汀（Q-D，每8小时30mg/kg体重）和万古霉素（每日两次，每次60mg/kg）单独使用或与利福平（每日两次，每次10mg/kg）联合使用的疗效。与万古霉素不同，与对照组相比，Q-D显著降低了每克骨组织中的平均log(10) 菌落形成单位数。利福平与Q-D或万古霉素联合使用均显著比单一疗法更有效。
相似文献
1
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.奎奴普丁-达福普汀（Synercid）与利福平联合使用，在实验性金黄色葡萄球菌人工关节感染中具有高度协同作用。
Antimicrob Agents Chemother. 2002 Apr;46(4):1122-4. doi: 10.1128/AAC.46.4.1122-1124.2002.
2
Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.由于耐甲氧西林金黄色葡萄球菌，利福平辅助治疗对优化达托霉素治疗兔人工关节感染的疗效至关重要。
Antimicrob Agents Chemother. 2011 Oct;55(10):4589-93. doi: 10.1128/AAC.00675-11. Epub 2011 Aug 8.
3
Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.奎奴普丁-达福普汀与利福平联合用药在体外以及针对对大环内酯-林可酰胺-链阳菌素抗生素具有不同耐药表型的金黄色葡萄球菌菌株所致实验性心内膜炎中的活性。
Antimicrob Agents Chemother. 2001 Apr;45(4):1244-8. doi: 10.1128/AAC.45.4.1244-1248.2001.
4
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.在兔关节炎模型中，奎奴普丁/达福普汀与万古霉素单独使用或与利福平联合使用对耐甲氧西林金黄色葡萄球菌的疗效。
Int J Antimicrob Agents. 2008 Feb;31(2):158-60. doi: 10.1016/j.ijantimicag.2007.09.004. Epub 2007 Nov 19.
5
Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.奎奴普丁-达福普汀与庆大霉素联合治疗耐甲氧西林金黄色葡萄球菌：兔心内膜炎实验研究
Antimicrob Agents Chemother. 2002 Jul;46(7):2174-8. doi: 10.1128/AAC.46.7.2174-2178.2002.
6
Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.对于不耐受先前治疗或先前治疗失败的患者，使用奎奴普丁-达福普汀治疗耐甲氧西林金黄色葡萄球菌感染。Synercid紧急使用研究组。
J Antimicrob Chemother. 2000 Nov;46(5):775-84. doi: 10.1093/jac/46.5.775.
7
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.链阳霉素加万古霉素治疗严重耐甲氧西林金黄色葡萄球菌和凝固酶阴性葡萄球菌感染：5例病例评估
Scand J Infect Dis. 2002;34(2):122-6. doi: 10.1080/00365540110077245.
8
Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci.使用奎奴普丁-达福普汀作为耐甲氧西林葡萄球菌感染重症患者抢救治疗的临床经验。
Intensive Care Med. 2002 Aug;28(8):1157-60. doi: 10.1007/s00134-002-1358-7. Epub 2002 Jun 20.
9
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.革兰氏阳性菌医院获得性肺炎的治疗。奎奴普丁/达福普汀与万古霉素的前瞻性随机对照研究。医院获得性肺炎研究组。
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):753-62. doi: 10.1164/ajrccm.161.3.9904115.
10
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的实验性异物感染的治疗
Antimicrob Agents Chemother. 1990 Dec;34(12):2312-7. doi: 10.1128/AAC.34.12.2312.
引用本文的文献
1
Prosthetic Joint Infection Research Models in NZW Rabbits: Opportunities for Standardization-A Systematic Review.新西兰白兔人工关节感染研究模型：标准化的机遇——一项系统评价
J Funct Biomater. 2024 Oct 15;15(10):307. doi: 10.3390/jfb15100307.
2
Animal experimental investigation on the efficacy of antibiotic therapy with linezolid, vancomycin, cotrimoxazole, and rifampin in treatment of periprosthetic knee joint infections by MRSA.利奈唑胺、万古霉素、复方新诺明和利福平抗生素治疗耐甲氧西林金黄色葡萄球菌所致人工膝关节周围感染疗效的动物实验研究
Bone Joint Res. 2022 Mar;11(3):143-151. doi: 10.1302/2046-3758.113.BJR-2021-0268.R1.
3
A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.在一种小鼠皮肤感染模型中，硫肽类细菌素微球菌素 P1 与利福平对耐甲氧西林金黄色葡萄球菌（MRSA）表现出强烈协同作用。
Front Immunol. 2021 Jul 2;12:676534. doi: 10.3389/fimmu.2021.676534. eCollection 2021.
4
Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.辅助利福平治疗伴有深部感染的金黄色葡萄球菌菌血症：一项荟萃分析。
PLoS One. 2020 Mar 19;15(3):e0230383. doi: 10.1371/journal.pone.0230383. eCollection 2020.
5
Emergency 1-stage anterior approach for cervical spine infection complicated by epidural abscess.颈椎感染合并硬膜外脓肿的急诊一期前路手术
Medicine (Baltimore). 2017 Jun;96(26):e7301. doi: 10.1097/MD.0000000000007301.
6
Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.头孢洛林酯在兔人工关节感染模型中对耐甲氧西林金黄色葡萄球菌的疗效。
Antimicrob Agents Chemother. 2014 Nov;58(11):6496-500. doi: 10.1128/AAC.03600-14. Epub 2014 Aug 18.
7
Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.头孢洛林体外抑制葡萄球菌杀白细胞素产生的效果和体内治疗兔社区相关耐甲氧西林金黄色葡萄球菌骨髓炎的效果。
Antimicrob Agents Chemother. 2012 Dec;56(12):6291-7. doi: 10.1128/AAC.00926-12. Epub 2012 Oct 1.
8
Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.由于耐甲氧西林金黄色葡萄球菌，利福平辅助治疗对优化达托霉素治疗兔人工关节感染的疗效至关重要。
Antimicrob Agents Chemother. 2011 Oct;55(10):4589-93. doi: 10.1128/AAC.00675-11. Epub 2011 Aug 8.
9
Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?细菌生长方式呈现独特的靶点：我们如何治疗生物膜介导的感染？
Curr Opin Microbiol. 2010 Oct;13(5):610-5. doi: 10.1016/j.mib.2010.09.007. Epub 2010 Sep 29.
10
Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.利福平增强达托霉素和万古霉素对依赖和不依赖于多糖细胞间黏附素（PIA）的表皮葡萄球菌生物膜的活性。
J Antimicrob Chemother. 2010 Oct;65(10):2164-71. doi: 10.1093/jac/dkq314. Epub 2010 Aug 18.
本文引用的文献
1
Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.奎奴普丁-达福普汀与利福平联合用药在体外以及针对对大环内酯-林可酰胺-链阳菌素抗生素具有不同耐药表型的金黄色葡萄球菌菌株所致实验性心内膜炎中的活性。
Antimicrob Agents Chemother. 2001 Apr;45(4):1244-8. doi: 10.1128/AAC.45.4.1244-1248.2001.
2
Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.42例由耐甲氧西林金黄色葡萄球菌流行菌株引起的败血症分析：对万古霉素耐药的证据
Clin Infect Dis. 2000 Sep;31(3):684-9. doi: 10.1086/314035. Epub 2000 Oct 4.
3
The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria.在恒定（1小时）或指数递减浓度的奎奴普丁/达福普汀作用下，对革兰氏阳性菌生物膜的影响。
J Antimicrob Chemother. 2000 Jul;46(1):61-7. doi: 10.1093/jac/46.1.61.
4
Wound infection in hip and knee arthroplasty.髋膝关节置换术中的伤口感染
J Bone Joint Surg Br. 2000 May;82(4):561-5. doi: 10.1302/0301-620x.82b4.10305.
5
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.1997年和1998年欧洲SENTRY抗菌药物监测项目中临床血液分离株的抗菌药物敏感性及出现频率
Clin Infect Dis. 2000 Mar;30(3):454-60. doi: 10.1086/313710.
6
Chemotherapy for gram-positive nosocomial sepsis.革兰氏阳性菌医院感染性败血症的化疗
J Chemother. 1999 Dec;11(6):446-52. doi: 10.1179/joc.1999.11.6.446.
7
The threat of vancomycin resistance.万古霉素耐药性的威胁。
Am J Med. 1999 May 3;106(5A):26S-37S; discussion 48S-52S. doi: 10.1016/s0002-9343(98)00354-4.
8
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.金黄色葡萄球菌中万古霉素耐药性的出现。糖肽类中介金黄色葡萄球菌工作组。
N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701.
9
Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.替考拉宁在人工关节假体金黄色葡萄球菌感染实验中的疗效及[14C]替考拉宁的放射自显影扩散模式
Antimicrob Agents Chemother. 1998 Nov;42(11):2830-5. doi: 10.1128/AAC.42.11.2830.
10
Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.金黄色葡萄球菌中赋予利福平抗性的rpoB基因突变的特征分析。
Antimicrob Agents Chemother. 1998 Oct;42(10):2590-4. doi: 10.1128/AAC.42.10.2590.
Zotero 插件